Media Watch: drug maker under scrutiny

Being accused of 'cheating the NHS' is enough to give anyone heartburn. So bosses at Reckitt Benckiser, makers of indigestion treatment Gaviscon, may well have sought comfort with a taste of their own medicine this week.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Already a subscriber? Sign into your account here